These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30351426)

  • 21. Introduction: Personalized medicine: what is it and what are the challenges?
    Sigman M
    Fertil Steril; 2018 Jun; 109(6):944-945. PubMed ID: 29935651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using observational data for personalized medicine when clinical trial evidence is limited.
    Gershman B; Guo DP; Dahabreh IJ
    Fertil Steril; 2018 Jun; 109(6):946-951. PubMed ID: 29935652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy.
    Almirall D; Compton SN; Gunlicks-Stoessel M; Duan N; Murphy SA
    Stat Med; 2012 Jul; 31(17):1887-902. PubMed ID: 22438190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision-support models for empiric antibiotic selection in Gram-negative bloodstream infections.
    MacFadden DR; Coburn B; Shah N; Robicsek A; Savage R; Elligsen M; Daneman N
    Clin Microbiol Infect; 2019 Jan; 25(1):108.e1-108.e7. PubMed ID: 29705558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
    Viscoli C; Bruzzi P; Glauser M
    Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A SMART design to optimize treatment strategies for patient and family caregiver outcomes.
    Song MK; DeVito Dabbs A; Ward SE
    Nurs Outlook; 2016; 64(4):299-305. PubMed ID: 27264454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying a set that contains the best dynamic treatment regimes.
    Ertefaie A; Wu T; Lynch KG; Nahum-Shani I
    Biostatistics; 2016 Jan; 17(1):135-48. PubMed ID: 26243172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential, Multiple Assignment, Randomized Trial Designs in Immuno-oncology Research.
    Kidwell KM; Postow MA; Panageas KS
    Clin Cancer Res; 2018 Feb; 24(4):730-736. PubMed ID: 28835379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMARTAR: an R package for designing and analyzing Sequential Multiple Assignment Randomized Trials.
    Zhong X; Cheng B; Wang X; Cheung YK
    PeerJ; 2021; 9():e10559. PubMed ID: 33510969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Sequential Multiple Assignment Randomized Trials (SMARTs) in oncology: systematic review of published studies.
    Lorenzoni G; Petracci E; Scarpi E; Baldi I; Gregori D; Nanni O
    Br J Cancer; 2023 Mar; 128(7):1177-1188. PubMed ID: 36572731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annual Research Review: Building a science of personalized intervention for youth mental health.
    Ng MY; Weisz JR
    J Child Psychol Psychiatry; 2016 Mar; 57(3):216-36. PubMed ID: 26467325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A breach in patients' safety in randomized controlled trials of antibiotic drugs.
    Leibovici L; Paul M
    J Antimicrob Chemother; 2013 Oct; 68(10):2179-80. PubMed ID: 23661594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.
    Kent DM; Steyerberg E; van Klaveren D
    BMJ; 2018 Dec; 363():k4245. PubMed ID: 30530757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards precision medicine in sepsis: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.
    Rello J; van Engelen TSR; Alp E; Calandra T; Cattoir V; Kern WV; Netea MG; Nseir S; Opal SM; van de Veerdonk FL; Wilcox MH; Wiersinga WJ
    Clin Microbiol Infect; 2018 Dec; 24(12):1264-1272. PubMed ID: 29581049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research.
    Lai TL; Liao OY; Kim DW
    Contemp Clin Trials; 2013 Nov; 36(2):651-63. PubMed ID: 23994669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personalized treatment of severe pneumonia in cancer patients.
    Rabello LS; Lisboa T; Soares M; Salluh JI
    Expert Rev Anti Infect Ther; 2015; 13(11):1319-24. PubMed ID: 26489538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A SMART data analysis method for constructing adaptive treatment strategies for substance use disorders.
    Nahum-Shani I; Ertefaie A; Lu XL; Lynch KG; McKay JR; Oslin DW; Almirall D
    Addiction; 2017 May; 112(5):901-909. PubMed ID: 28029718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients.
    Mol BW; Bossuyt PM; Sunkara SK; Garcia Velasco JA; Venetis C; Sakkas D; Lundin K; Simón C; Taylor HS; Wan R; Longobardi S; Cottell E; D'Hooghe T
    Fertil Steril; 2018 Jun; 109(6):968-979. PubMed ID: 29935655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Respiratory Infections with Use of Procalcitonin: Moving toward More Personalized Antibiotic Treatment Decisions.
    Wirz Y; Branche A; Wolff M; Welte T; Nobre V; Reinhart K; Falsey AR; Damas P; Beishuizen A; Deliberato RO; Shehabi Y; Jensen JS; Mueller B; Schuetz P
    ACS Infect Dis; 2017 Dec; 3(12):875-879. PubMed ID: 29120606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Power analysis in a SMART design: sample size estimation for determining the best embedded dynamic treatment regime.
    Artman WJ; Nahum-Shani I; Wu T; Mckay JR; Ertefaie A
    Biostatistics; 2020 Jul; 21(3):432-448. PubMed ID: 30380020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.